Department of Interventional Ultrasound, Chinese People's Liberation Army General Hospital, 28 Fuxing Road, Beijing 100853, PR China.
Eur J Radiol. 2012 Mar;81(3):437-40. doi: 10.1016/j.ejrad.2010.12.056. Epub 2011 Jan 15.
With evolving local thermal ablation technology, the clinical application of thermal ablation has been actively investigated in the treatment for renal cell carcinoma. We review the evolution and current status of radiofrequency ablation and microwave ablation for renal cell carcinoma.
All articles published in English on radiofrequency ablation or microwave ablation as a treatment for renal cell carcinoma were identified with a MEDLINE® and PubMed® search from 1990 to 2010.
Local thermal ablation has several advantages, including keeping more normal renal units, relatively simple operation, easy tolerance, fewer complications, a shorter hospitalization and convalescence period. Long-term data has determined radiofrequency ablation is responsible for poor surgical candidates with renal cell carcinoma, however, tumor size, location and shape might affect the efficacy of radiofrequency ablation. Microwave ablation can induce large ablation volumes and yield good local tumor control. Associated complications appear to be low.
Local ablative approaches seem to represent an attractive alternative to extirpative surgery for the treatment of small renal neoplasms in select patients. Potential developments include concepts to improve the accuracy and effectiveness of thermal ablation by improving the guiding, monitoring capabilities and detection capacity of multi-center lesions to provide at least equivalent cancer control to conventional surgery.
随着局部热消融技术的不断发展,热消融在治疗肾细胞癌中的临床应用得到了积极的探索。我们回顾了射频消融和微波消融治疗肾细胞癌的发展历程和现状。
通过 MEDLINE® 和 PubMed® 数据库,检索了 1990 年至 2010 年间发表的关于射频消融或微波消融治疗肾细胞癌的所有英文文献。
局部热消融具有保留更多正常肾单位、操作相对简单、易于耐受、并发症较少、住院和康复时间较短等优点。长期数据表明,射频消融适用于不能手术的肾细胞癌患者,但肿瘤大小、位置和形状可能影响射频消融的疗效。微波消融可以诱导较大的消融体积,获得良好的局部肿瘤控制。相关并发症似乎较低。
局部消融方法似乎是一种有吸引力的替代根治性手术的选择,适用于特定患者的小肾肿瘤治疗。潜在的发展包括通过改进引导、监测能力和多中心病变的检测能力来提高热消融的准确性和有效性,以提供至少与传统手术相当的癌症控制效果。